Immunocore initial data for HIV functional cure candidate

 Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025

IMC-M113V was well tolerated, with no dose-limiting toxicities

Signals of dose-dependent reduction in active reservoir, and viral control after complete antiretroviral treatment interruption in some PLWH

Enrollment in MAD portion of the trial continues with higher doses being evaluated

https://www.globenewswire.com/news-release/2025/03/10/3040106/0/en/Immunocore-presents-initial-multiple-ascending-dose-data-for-HIV-functional-cure-candidate-in-an-oral-presentation-at-CROI-2025.html